CSTL vs EFX · rev $187.2M vs P/E 54, rev $3.35B
Castle Biosciences Inc (CSTL) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
CSTL currently screens at market cap $570.2M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the CSTL and EFX stock pages for the full models.
Not investment advice.